Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Single-Cell Analysis By Mass Cytometry Reveals CD19 CAR T Cell Spatiotemporal Plasticity in Patients

Lior Goldberg, Eric R Haas, Vibhuti Vyas, Ryan Urak, Stephen J Forman, Xiuli Wang

Blood (2021) 138 (Supplement 1): 2794.

https://doi.org/10.1182/blood-2021-153444

Published: 2021

Journal Articles

Use of RNA Interference to Inhibit Integrin Subunit alphaV-Mediated Angiogenesis.

Thorsten T. Graef, MD, Ulrich U. Steidl, MD, Roland R. Fenk, MD, Ulrich U. Rohr, MD, Wolfgang W. Nedbal, MD, Rainer R. Haas, MD, Ralf R. Kronenwett, MD

Blood (2004) 104 (11): 5258.

https://doi.org/10.1182/blood.V104.11.5258.5258

Published: 2004

Journal Articles

Early Myeloablative Allogeneic Stem Cell Transplantation during High-Dose Cytarabin Induced Cytopenia in Patients with Refractory or Relapsed Myeloid Leukemias.

Thorsten T. Graef, MD, Frank F. Neumann, MD, Roland R. Fenk, MD, Mustafa M. Kondakci, MD, Lailani L. Ruf, MD, Ulrich U. Steidl, MD2, Rainer R. Haas, MD, Guido G. Kobbe, MD

Blood (2004) 104 (11): 100.

https://doi.org/10.1182/blood.V104.11.100.100

Published: 2004

Journal Articles

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

HH Euler, AM Marmont, A Bacigalupo, S Fastenrath, P Dreger, M Hoffknecht, AR Zander, B Schalke, U Hahn, R Haas, N Schmitz

Blood (1996) 88 (9): 3621–3625.

https://doi.org/10.1182/blood.V88.9.3621.bloodjournal8893621

Published: 1996

Journal Articles

Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support

R Haas, B Witt, R Mohle, H Goldschmidt, S Hohaus, S Freuhauf, M Wannenmacher, W Hunstein

Blood (1995) 85 (12): 3754–3761.

https://doi.org/10.1182/blood.V85.12.3754.bloodjournal85123754

Published: 1995

Journal Articles

Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy [see comments]

S Fruehauf, R Haas, C Conradt, S Murea, B Witt, R Mohle, W Hunstein

Blood (1995) 85 (9): 2619–2626.

https://doi.org/10.1182/blood.V85.9.2619.bloodjournal8592619

Published: 1995

Journal Articles

Blood-derived autografts collected during granulocyte colony- stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells

R Haas, R Mohle, M Pforsich, S Fruehauf, B Witt, H Goldschmidt, W Hunstein

Blood (1995) 85 (7): 1936–1943.

https://doi.org/10.1182/blood.V85.7.1936.bloodjournal8571936

Published: 1995

Journal Articles

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

R Haas, R Mohle, S Fruhauf, H Goldschmidt, B Witt, M Flentje, M Wannenmacher, W Hunstein

Blood (1994) 83 (12): 3787–3794.

https://doi.org/10.1182/blood.V83.12.3787.3787

Published: 1994

Journal Articles

Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma

AD Ho, R Haas, G Wulf, W Knauf, R Ehrhardt, B Heilig, M Korbling, G Schulz, W Hunstein

Blood (1990) 75 (1): 203–212.

https://doi.org/10.1182/blood.V75.1.203.203

Published: 1990

Journal Articles

Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia

M Korbling, W Hunstein, TM Fliedner, S Cayeux, B Dorken, D Fehrentz, R Haas, AD Ho, U Keilholz, W Knauf

Blood (1989) 74 (6): 1898–1904.

https://doi.org/10.1182/blood.V74.6.1898.1898

Published: 1989

Journal Articles

T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2

S Cayeux, S Meuer, A Pezzutto, M Korbling, R Haas, R Schulz, B Dorken

Blood (1989) 74 (6): 2270–2277.

https://doi.org/10.1182/blood.V74.6.2270.2270

Published: 1989

Journal Articles

Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin- 2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2

S Cayeux, S Meuer, A Pezzutto, M Korbling, R Haas, R Schulz, B Dorken

Blood (1989) 74 (6): 2278–2284.

https://doi.org/10.1182/blood.V74.6.2278.2278

Published: 1989

Journal Articles

B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation

S Kiesel, A Pezzutto, G Moldenhauer, R Haas, M Korbling, W Hunstein, B Dorken

Blood (1988) 72 (2): 672–678.

https://doi.org/10.1182/blood.V72.2.672.672

Published: 1988

NARROW

Single-Cell Analysis By Mass Cytometry Reveals CD19 CAR T Cell Spatiotemporal Plasticity in Patients

Use of RNA Interference to Inhibit Integrin Subunit alphaV-Mediated Angiogenesis.

Early Myeloablative Allogeneic Stem Cell Transplantation during High-Dose Cytarabin Induced Cytopenia in Patients with Refractory or Relapsed Myeloid Leukemias.

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support

Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy [see comments]

Blood-derived autografts collected during granulocyte colony- stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma

Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia

T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2

Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin- 2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2

B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only